Finvest
CON Healthcare Services · Occupational health · Workers comp · Mid cap · Thesis updated July 12, 2026

Concentra is scaling a steady work-health network

01 Running thesis

Growth is proving out

Concentra's case improved after Q1 2026. Revenue grew 13.7% year over year to $569.6 million. Adjusted EBITDA grew 17.6% to $120.7 million, and margin rose to 21.2%. That means the company is getting more profit from each dollar of sales while still adding acquired clinics.

The strongest change is in Onsite Health Clinics. That business grew 125% reported in Q1 2026, helped by the Pivot Onsite Innovations deal. It also grew 20.9% organically, which means growth from the existing base before the deal impact. If that pace holds, onsite care can become more than a small add-on to the core centers.

The bull case is simple: Concentra has the largest U.S. occupational health network by locations, has finished major integrations ahead of plan, and raised 2026 revenue, adjusted EBITDA, and free cash flow guidance. Share repurchases also show management is willing to return cash while it grows.

The bear case is not broken. Visits depend on employers hiring, keeping workers active, and sending injured workers to Concentra. Debt still matters, and the stock's valuation leaves less room for mistakes. The PJ&A data breach lawsuits are also an open tail risk because the final cost is not yet clear.

May 2026Q1 2026 strengthened the thesis. Revenue rose 13.7%, adjusted EBITDA rose 17.6%, margin reached 21.2%, and management raised 2026 guidance.
May 2026The Q1 2026 10-Q showed growth from both visits and revenue per visit. Onsite Health Clinics rose to 7% of revenue, and the company repurchased $15.0 million of stock.
Feb 2026The 2025 10-K showed full-year revenue of $2.1634 billion and a larger onsite business. It also confirmed a $100 million buyback program, while giving more detail on the PJ&A data breach risk.
Nov 2025Q3 2025 revenue grew 17.0%, and Onsite Health Clinics doubled its revenue share versus the prior year quarter. The company also paid down its revolving credit facility.
Aug 2025Q2 2025 showed stronger visit growth, with total visits per day up 9.5% and revenue per visit up 4.4%. The Pivot Onsite Innovations deal expanded the onsite clinic base to over 400 locations.
May 2025Q1 2025 reversed the prior employer services volume concern. Employer services visits per day grew 3.9%, and the planned Pivot deal pointed to a larger onsite strategy.
Mar 2025The 2024 10-K showed good pricing power but still weak employer services volume. The Nova Medical Centers deal added 67 clinics, while new public-company, debt, and data-breach risks became clearer.
Nov 2024Q3 2024 showed the old tension in the story. Revenue per visit rose 3.9%, but employer services visits per day fell 4.1%.
02 Business model

Paid when workers need care

Concentra sells healthcare services to employers and their workers. The main work happens in stand-alone occupational health centers and onsite clinics at employer locations. Employers use Concentra for injury treatment, physical therapy, drug tests, physical exams, and other job-related medical needs.

Workers' compensation is the higher-revenue service line. It includes care for work injuries and related rehab. Employer services are higher volume, but lower revenue per visit. These include drug screens, physicals, clinical testing, and preventive care.

Scale is the moat. As of March 31, 2026, Concentra had 632 stand-alone occupational health centers and 411 onsite health clinics. That lets it serve small businesses and large national employers with one network.

The model can break if work slows. Fewer hires can mean fewer pre-employment tests. Fewer active workers can mean fewer workplace injuries. State fee schedules also matter because workers' comp payment rates are often set or shaped at the state level.

03 Product portfolio

Three core services, one new push

Cash cow

Workers' Compensation Services

This is Concentra's highest-revenue service line. It treats work injuries, runs physical rehab, and coordinates specialist care.

Steady

Employer Services

This is the highest-volume service line. It includes drug and alcohol screens, physical exams, clinical testing, and other required job-health services.

Option

Consumer Health Services

This is a small urgent-care offering for non-work injuries and illnesses. It represented about 2% of visits and revenue in 2025.

Growth engine

Advanced Primary Care

This is the newer push inside onsite clinics. Concentra is trying to move beyond basic occupational health into more complete primary care at the worksite.

04 Business segments

Centers still carry the company

Occupational Health Centers91%modest
Onsite Health Clinics7%growing fast
Other Businesses2%flat

The mix is from Q1 2026 revenue by operating segment. Occupational Health Centers still dominate, but Onsite Health Clinics rose from 3% of revenue in Q1 2025 to 7% in Q1 2026.

05 Risk factors

What could go wrong

Labor market slowdown

High impact · Medium odds

Concentra benefits when employers are hiring, testing, and managing active workforces. A weaker blue-collar labor market could lower employer services visits and workers' comp volumes. Management described the current setting as stable, but that can change quickly.

We watchTrack total visits, visits per day, employer services volume, and U.S. employment trends in industrial and service jobs.

Workers' comp fee pressure

High impact · Medium odds

Workers' compensation is the highest-revenue service line. Many payment rates depend on state rules and fee schedules. If key states cut rates or limit approved treatments, revenue per visit could weaken.

We watchWatch revenue per visit and state workers' compensation fee schedule changes in Concentra's largest states.

Debt limits flexibility

Medium impact · Medium odds

Concentra had substantial indebtedness of about $1.57 billion at year-end 2025. Management is targeting net debt to adjusted EBITDA below 3.0x by year-end 2026. If growth slows, debt could limit buybacks, M&A, or reinvestment.

We watchWatch net debt to adjusted EBITDA, interest expense, covenant disclosures, and any change in buyback pace.

PJ&A data breach lawsuits

High impact · Low odds

A third-party vendor breach led Concentra to notify almost four million patients in early February 2024. The company says it is subject to several related lawsuits. The risk is hard to size because legal fees, settlements, and possible fines are still open questions.

We watchWatch legal accruals, settlement announcements, insurance recovery disclosures, and updates in SEC filings.

Onsite growth fades after acquisitions

Medium impact · Medium odds

Onsite Health Clinics grew fast in Q1 2026, but part of that came from the Pivot acquisition. The key test is whether organic growth stays strong after the acquired clinics are fully in the base. Margins in advanced primary care also need to prove out as the business scales.

We watchWatch Onsite organic growth, segment revenue share, clinic count, and any margin comments from management.
06 Quick answers

In one breath

What does Concentra do?

Concentra provides occupational health services in the United States. It treats workplace injuries, runs physical therapy, performs drug screens and job physicals, and operates clinics at employer worksites.

How does Concentra make money?

Most revenue comes from services tied to employers and their workers. Workers' compensation visits bring higher revenue per visit, while employer services bring more volume.

Why is the Onsite Health Clinics segment important?

It is growing much faster than the core business. In Q1 2026, reported onsite revenue grew 125%, and organic revenue grew 20.9%, giving Concentra a path to expand beyond traditional occupational health.

What is the biggest risk for CON stock?

The biggest business risk is a weaker labor market, because fewer hires and fewer active workers can reduce visits. Debt, workers' comp rate changes, and the PJ&A data breach lawsuits also matter.